Maharashtra FDA revokes licence for Cipla's Pune distribution centre
The Maharashtra Food and Drug Administration (FDA) has revoked the drug distribution licences for the Cipla Pharma & Life Sciences Carry & Forwarding unit located in Wadki, Pune, after conducting an inspection. Officials identified major violations concerning the storage, packaging, documentation, and recall procedures for Reactin Plus Tablets. The FDA reported that drugs were being kept directly on the floor and noted a lack of proper rack and pallet systems.